These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30753298)

  • 21. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
    Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
    PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine Models of Acute Myeloid Leukaemia.
    Almosailleakh M; Schwaller J
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells.
    Nishida Y; Maeda A; Kim MJ; Cao L; Kubota Y; Ishizawa J; AlRawi A; Kato Y; Iwama A; Fujisawa M; Matsue K; Weetall M; Dumble M; Andreeff M; Davis TW; Branstrom A; Kimura S; Kojima K
    Blood Cancer J; 2017 Feb; 7(2):e527. PubMed ID: 28211885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
    Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
    J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models.
    Portwood S; Lal D; Hsu YC; Vargas R; Johnson MK; Wetzler M; Hart CP; Wang ES
    Clin Cancer Res; 2013 Dec; 19(23):6506-19. PubMed ID: 24088735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
    Karantanos T; Jones RJ
    Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
    Su R; Gong JN; Chen MT; Song L; Shen C; Zhang XH; Yin XL; Ning HM; Liu B; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    Oncotarget; 2016 Nov; 7(47):77430-77443. PubMed ID: 27764807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
    Wang Y; Zhou Q; Ma JJ
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiocidin induces differentiation of acute myeloid leukemia cells.
    Tuszynski GP; Rothman VL
    Exp Mol Pathol; 2013 Dec; 95(3):249-54. PubMed ID: 24036285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of ZFAS1 suppresses the progression of acute myeloid leukemia by regulating microRNA-150/Sp1 and microRNA-150/Myb pathways.
    Gan S; Ma P; Ma J; Wang W; Han H; Chen L; Li X; Wu F; Sun H
    Eur J Pharmacol; 2019 Feb; 844():38-48. PubMed ID: 30502345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digitalization of a non-irradiated acute myeloid leukemia model.
    Li R; Cheng H; Cheng T; Liu L
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):64. PubMed ID: 27585558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up.
    Boyer T; Gonzales F; Plesa A; Peyrouze P; Barthelemy A; Guihard S; Quesnel B; Roumier C; Preudhomme C; Cheok M
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29630051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.
    Wang L; Cai W; Zhang W; Chen X; Dong W; Tang D; Zhang Y; Ji C; Zhang M
    Oncotarget; 2015 Sep; 6(29):27490-504. PubMed ID: 26314963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
    Cornet-Masana JM; Moreno-Martínez D; Lara-Castillo MC; Nomdedeu M; Etxabe A; Tesi N; Pratcorona M; Esteve J; Risueño RM
    Oncotarget; 2016 Apr; 7(17):23239-50. PubMed ID: 26992240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
    Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
    Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.